
    
      This study is to compare the efficacy and safety of HE10 and Restasis for patients with
      moderate to severe dry eye syndrome in multi-center, double-blind, randomized, active
      comparator-controlled, parallel design, non-inferiority Phase III clinical trial.
    
  